| scholarly article | Q13442814 |
| P2093 | author name string | Toyoaki Murohara | |
| Yasushi Numaguchi | |||
| Takeshi Sasaki | |||
| Keiko Maeda | |||
| Takahisa Kondo | |||
| Kae Nakamura | |||
| Akihisa Iguchi | |||
| Mitsuhiro Yokota | |||
| Xian Wu Cheng | |||
| Masafumi Kuzuya | |||
| Zexuan Liu | |||
| Weon Kim | |||
| Hai Jin | |||
| Kenji Okumura | |||
| Michitaka Tsuzuki | |||
| Natsuo Inoue | |||
| P433 | issue | 6 | |
| P921 | main subject | neovascularization | Q1281049 |
| P304 | page(s) | 904-913 | |
| P577 | publication date | 2007-02-22 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice | |
| P478 | volume | 100 |
| Q35870375 | Angiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice |
| Q34576771 | Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients |
| Q33927282 | CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow |
| Q47616758 | Cathepsin K activity controls cardiotoxin-induced skeletal muscle repair in mice |
| Q41769190 | Cathepsin K activity controls injury-related vascular repair in mice |
| Q35181072 | Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia. |
| Q37444377 | Cell therapies for therapeutic angiogenesis: back to the bench |
| Q47099656 | Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis |
| Q36482251 | Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension |
| Q41855551 | Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2. |
| Q36211889 | Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease |
| Q27333560 | Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14 |
| Q33608094 | Electrical Stimulation of Denervated Rat Skeletal Muscle Retards Capillary and Muscle Loss in Early Stages of Disuse Atrophy |
| Q37361789 | Endothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity |
| Q28303395 | Endothelial progenitor cells: identity defined? |
| Q34765925 | Exercise Training Stimulates Ischemia-Induced Neovascularization via Phosphatidylinositol 3-Kinase/Akt-Dependent Hypoxia-Induced Factor-1α Reactivation in Mice of Advanced Age |
| Q33813584 | Exercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q37446733 | In Vivo Angiogenic Capacity of Stem Cells from Human Exfoliated Deciduous Teeth with Human Umbilical Vein Endothelial Cells |
| Q35753850 | Increased Circulating Cathepsin K in Patients with Chronic Heart Failure |
| Q37720701 | Intratracheal transplantation of endothelial progenitor cells attenuates smoking-induced COPD in mice. |
| Q37142364 | Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q84803519 | Matrix metalloproteinase‐2 regulates the expression of tissue inhibitor of matrix metalloproteinase‐2 |
| Q33997747 | Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers |
| Q41660993 | Mitochondrial-Targeted Antioxidant Maintains Blood Flow, Mitochondrial Function, and Redox Balance in Old Mice Following Prolonged Limb Ischemia |
| Q35172537 | Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. |
| Q53530651 | OPC-28326, a selective peripheral vasodilator with angiogenic activity, mitigates postinfarction cardiac remodeling. |
| Q28506359 | OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization |
| Q61817409 | Phorbol ester-induced angiogenesis of endothelial progenitor cells: The role of NADPH oxidase-mediated, redox-related matrix metalloproteinase pathways |
| Q39148627 | Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. |
| Q53392996 | Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy. |
| Q43056288 | Repeated phlebotomy augments angiogenesis to improve blood flow in murine ischemic legs |
| Q36427681 | Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma |
| Q92541787 | Role of Matrix Metalloproteinases in Angiogenesis and Cancer |
| Q26824706 | Role of exercise in the prevention of cardiovascular disease: results, mechanisms, and new perspectives |
| Q36778223 | Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment |
| Q38674890 | The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice |
| Q37010693 | The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells |
| Q36855676 | Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis |
| Q42496459 | Tissue Inhibitor of Metalloproteinase 1 Influences Vascular Adaptations to Chronic Alterations in Blood Flow |
| Q33794302 | Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors |
| Q36682256 | Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. |
| Q42257428 | Vasculogenic cytokines in wound healing |
Search more.